Trial intelligence / Profile preview

Prospective randomized open study comparing fondaparinux with enoxaparin in femoro-distal venous bypass surgery

2007-003746-15Phase 4Active

Sponsor
Ammerland-Klinik
Start
Feb 2008
Modality
Recombinant Proteins and Enzymes, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in peripheral artery occlusion (PAD) comparing Fondaparinux (Arixtra) arm with Enoxaparin (Clexane) arm (2 arms). Primary endpoint: Postoperative bypass patency. Started Feb 2008; status: active.

02

Drugs

fondaparinuxenoxaparin
03

Conditions

peripheral artery occlusion (PAD)

Beyond the preview

Go deeper on 2007-003746-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003746-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call